← All roles

Chief of Staff

Mytos· Operations
Apply on company site
Hybrid (London)£70k - £120kFull-timePosted 8mo ago

About the role

Smart, analytical Chief of Staff to accelerate growth across Recruiting, Finance, new product areas, and Operations. High autonomy, exposure to founders and advisors, with a focus on solving high-priority company challenges and preparing for fundraising.

Responsibilities

  • Solving the highest priority company challenges to ensure we achieve our goals
  • Work on multiple projects in parallel that will require you to be adaptable across multiple functions
  • Streamline processes across the company
  • Prepare the organisation for fundraising that can fuel our fast paced growth

Qualifications

  • Strong analytical ability and capable of learning quickly
  • 5+ yrs experience in a startup/investment banking/consulting background, where you’re used to learning fast, working hard, and thinking analytically
  • Track record of being a top performer in several different areas
  • Excellent written and verbal communication skills
  • Have a STEM or other highly quantitative degree from a globally recognised university
  • A desire to have a high impact, and to work in an environment where you have high autonomy and decision making agency to influence the direction

Skills

Required:Analytical thinkingProject managementCommunicationSTEM degree

Benefits

  • Competitive salary with stock options
  • Lunch covered daily
  • Collaborative team environment with very high potential to learn new skills
  • 24 days holiday (excluding bank holidays)
  • Pension
  • Office in the Imperial College Innovation hub in White City
Last updated Jun 5, 2026. Interested? Apply on the company site.
Mytos logo

About Mytos

Robotic human cell manufacturing

Mytos builds robots for manufacturing human cells. Operators input stem cells, and our platform turns them into specific cells such as neurons and heart cells over multiple weeks. Last year, patients were cured of Parkinson’s, vision loss, and Type 1 diabetes using stem-cell derived cells. We need 1000x the global capacity to produce these cells, and treat millions of patients. But today these Regenerative Medicines are produced by hand, meaning they’re too expensive and don’t scale. Mytos has fully automated production of these cells, making it scalable. We have our first manufacturing deal - neurons for treating Parkinson’s - and we’re in conversations with majority of the other top players.

hardwareiotbiotechautomationbiotechnology

More open roles at Mytos